Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 179 participants.
Also called NCT01687491
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 179 participants
- Sponsor
- Les Laboratoires des Médicaments Stériles
- Registry
-
NCT01687491
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Tunisia
- Registry status
- Completed
Technical summary
Registry record NCT01687491. Randomized; single masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2013-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome
- Acronym
- AXA
- Condition
- Acute Coronary Syndrome
- Condition
- Factor X
- Intervention (Drug)
- ENOXA®
- Intervention (Drug)
- LOVENOX®
- Lead sponsor
- Les Laboratoires des Médicaments Stériles
- Collaborator
- University Hospital Fattouma Bourguiba
Record details
- Record id
cardio:ct-nct01687491- Content hash
954e2fb97d21acc44bd869629056bdef8ca13aefa01214e2c81a6c11ef38a090